Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of Leuco methylthioninium bis(hydromethanesulfonate) in Subjects with Mild to Moderate Alzheimer's Disease (2013-2017)
Experts
Professor
Gerard Byrne
Mayne Professor of Psychiatry
Medical School
Faculty of Health, Medicine and Behavioural Sciences
